TrialJournal of the European Academy of Dermatology and Venereology : JEADV2022

Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances.

S Ständer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.